These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7246599)

  • 1. Severe leukopenia and mild thrombocytopenia after chronic bromocriptine (CB-154) administration.
    Giampietro O; Ferdeghini M; Petrini M
    Am J Med Sci; 1981; 281(3):169-72. PubMed ID: 7246599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial hypopituitarism and hyperprolactinemia: successful induction of ovulation with bromocriptine and human menopausal gonadotropins.
    Dawood MY; Jarrett JC; Choe JK
    Fertil Steril; 1982 Oct; 38(4):415-8. PubMed ID: 6811337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bromocriptine in the treatment of hyperolactinemic amenorrhea.
    Badano AR; Miechi HR; Mirkin A; Arcángeli OA; Aparicio NJ; Rodríguez A; Oliva A; Turner D; Figueroa Casas PR
    Fertil Steril; 1979 Feb; 31(2):124-9. PubMed ID: 570131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoration of ovarian function by low nocturnal single daily doses of bromocriptine in patients with the galactorrhea-amenorrhea syndrome.
    de Bernal M; de Villamizar M
    Fertil Steril; 1982 Mar; 37(3):392-6. PubMed ID: 6800849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of functional amenorrhea-galactorrhea with 2-bromoergocryptine.
    Wiebe RH; Hammond CB; Handwerger S
    Fertil Steril; 1977 Apr; 28(4):426-33. PubMed ID: 321260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperprolactinemic primary amenorrhea: case report with successful prolactin-lowering treatment and review of the literature.
    Farrari C; Telloli P; Rampini P; Caldara R
    Gynecol Obstet Invest; 1980; 11(6):317-26. PubMed ID: 6785158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the efficacy and safety of pergolide and bromocriptine in the treatment of hyperprolactinemia.
    Lamberts SW; Quik RF
    J Clin Endocrinol Metab; 1991 Mar; 72(3):635-41. PubMed ID: 1997518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of hyperprolactinemic amenorrhea by intermittent administration of bromocryptine (CB 154).
    Polatti E; Bolis PF; Ravagni-Probizer MF; Baruffini A; Cavalleri A
    Am J Obstet Gynecol; 1978 Aug; 131(7):792-6. PubMed ID: 567429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of the action of bromocriptine in hyperprolactinemic states. Results of a cooperative trial in 135 patients].
    Fossati P; Strauch G; Tourniaire J
    Nouv Presse Med; 1976 Jul 3-10; 5(27):1687-91. PubMed ID: 986640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe leukopenia and thrombocytopenia secondary to quinidine.
    Nair MR; Duvernoy WF; Leichtman DA
    Clin Cardiol; 1981; 4(5):247, 257. PubMed ID: 7307362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation of serum prolactin-releasing activity in women with the galactorrhea-amenorrhea syndrome after bromocriptine treatment.
    Takahashi K; Minato K; Ikeno N; Watanabe M; Endo H; Yamamoto H
    Am J Obstet Gynecol; 1983 May; 146(1):74-9. PubMed ID: 6405619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperprolactinemia. Long-term effects of bromocriptine.
    Johnston DG; Prescott RW; Kendall-Taylor P; Hall K; Crombie AL; Hall R; McGregor A; Watson MJ; Cook DB
    Am J Med; 1983 Nov; 75(5):868-74. PubMed ID: 6638052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group.
    Webster J; Piscitelli G; Polli A; Ferrari CI; Ismail I; Scanlon MF
    N Engl J Med; 1994 Oct; 331(14):904-9. PubMed ID: 7915824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical course and outcome of thirty-five pregnancies in infertile hyperprolactinemic women.
    Skrabanek P; McDonald D; Meagher D; de Valera E; Carroll C; Lanigan O; Powell D
    Fertil Steril; 1980 Apr; 33(4):391-5. PubMed ID: 7364069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A broad spectrum of prolactin suppression by bromocriptine in hyperprolactinemic women: a study of serum prolactin and bromocriptine levels after acute and chronic admknistration of bromocriptine.
    Thorner MO; Schran HF; Evans WS; Rogol AD; Morris JL; MacLeod RM
    J Clin Endocrinol Metab; 1980 Jun; 50(6):1026-33. PubMed ID: 7189523
    [No Abstract]   [Full Text] [Related]  

  • 16. Normalization of visual fields following bromocriptine treatment in hyperprolactinemic patients with visual field constriction.
    Vaidya RA; Aloorkar SD; Rege NR; Maskati BT; Jahangir RP; Sheth AR; Pandya SK
    Fertil Steril; 1978 Jun; 29(6):632-6. PubMed ID: 566222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicted ovulatory response to 2-brom-alpha-ergocryptine (CB-154) in amenorrhea-galactorrhea syndromes.
    Shewchuk AB; Corenblum B; Pairaudeau N; Ezrin C; Adamson GD
    Am J Obstet Gynecol; 1980 Mar; 136(5):652-8. PubMed ID: 7188835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of ovulation in patients with normoprolactinemic amenorrhea by combined therapy with bromocriptine and clomiphene.
    Koike K; Aono T; Miyake A; Tsutsumi H; Matsumoto K; Kurachi K
    Fertil Steril; 1981 Feb; 35(2):138-41. PubMed ID: 6781935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amenorrhea and galactorrhea: results of therapy with 2-Brom-alpha-ergocryptine (CB-154).
    Lloyd SJ; Josimovich JB; Archer DF
    Am J Obstet Gynecol; 1975 May; 122(1):85-9. PubMed ID: 1168997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregnancy following combined therapy with thyroid hormone and bromocriptine in a patient with amenorrhea-galactorrhea due to primary hypothyroidism.
    Matsuura K; Mizumoto J; Matsui K; Maeyama M
    Int J Fertil; 1982; 27(3):181-3. PubMed ID: 6128325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.